1061 fundamentals
ESSEX BIO-TECHNOLOGY financial statements, including revenue, expenses, and profit
The total revenue of 1061 for the last semiannual is 858.19 M HKD, and it's 5.74% higher compared to the previous semiannual. The net income of H2 24 is 149.78 M HKD.
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: HKD
TTM